Suppr超能文献

具有KCNJ5突变的日本醛固酮瘤的特征

Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.

作者信息

Okamura Takashi, Nakajima Yasuyo, Katano-Toki Akiko, Horiguchi Kazuhiko, Matsumoto Shunichi, Yoshino Satoshi, Yamada Eijiro, Tomaru Takuya, Ishii Sumiyasu, Saito Tsugumichi, Ozawa Atsushi, Shibusawa Nobuyuki, Satoh Tetsurou, Okada Shuichi, Nagaoka Rin, Takada Daisuke, Horiguchi Jun, Oyama Tetsunari, Yamada Masanobu

机构信息

Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan.

出版信息

Endocr J. 2017 Jan 30;64(1):39-47. doi: 10.1507/endocrj.EJ16-0243. Epub 2016 Sep 28.

Abstract

Somatic mutations in KCNJ5 gene have been identified in patients with adrenal aldosterone-producing adenomas (APAs). We previously reported that Japanese patients with APAs had distinct characteristics from patients in Western countries; i.e. they had a high frequency of KCNJ5 mutations and exhibited a frequent association with cortisol co-secretion. Therefore, APAs among Japanese patients may have different features from those in Western countries. We added recent cases, examined 47 cases (43% male) of APAs, including clinicopathological features, KCNJ5 mutations, and the mRNA levels of several steroidogenic enzymes, and compared the results obtained to those reported in other countries. While the prevalence of KCNJ5 mutations is approximately 40% in Western countries, 37 APA cases (78.7%) showed mutations: 26 with p.G151R and 11 with p.L168R. Although a significant gender difference has been reported in the frequency of KCNJ5 mutations in Europe, we did not find any gender difference. However, the phenotypes of Japanese patients with mutations were similar to those of patients in Western countries; patients were younger and had higher plasma aldosterone levels, lower potassium levels, and higher diastolic blood pressure. Reflecting these phenotypes, APAs with mutations had higher CYP11B2 mRNA levels. However, in contrast to APAs in Western countries, Japanese APAs with mutations showed lower CYP11B1, CYP17A1, and CYP11A1 mRNA levels. These findings demonstrated that Japanese APA patients may have distinct features including a higher prevalence of KCNJ5 mutations, no gender difference in the frequency of these mutations, and characteristics similar to the zona glomerulosa.

摘要

在肾上腺醛固酮分泌性腺瘤(APA)患者中已鉴定出KCNJ5基因的体细胞突变。我们之前报道过,日本APA患者具有与西方国家患者不同的特征;即他们KCNJ5突变频率高,且常伴有皮质醇共分泌。因此,日本患者中的APA可能具有与西方国家不同的特征。我们纳入了近期病例,检查了47例(43%为男性)APA患者,包括临床病理特征、KCNJ5突变以及几种类固醇生成酶的mRNA水平,并将所得结果与其他国家报道的结果进行比较。虽然西方国家KCNJ5突变的患病率约为40%,但37例APA患者(78.7%)显示有突变:26例为p.G151R突变,11例为p.L168R突变。尽管欧洲报道KCNJ5突变频率存在显著性别差异,但我们未发现任何性别差异。然而,日本突变患者的表型与西方国家患者相似;患者更年轻,血浆醛固酮水平更高,血钾水平更低,舒张压更高。反映这些表型的是,有突变的APA患者CYP11B2 mRNA水平更高。然而,与西方国家的APA不同,日本有突变的APA患者CYP11B1、CYP17A1和CYP11A1 mRNA水平更低。这些发现表明,日本APA患者可能具有独特特征,包括KCNJ5突变患病率更高、这些突变频率无性别差异以及与球状带相似的特征。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验